학술논문

NABNEC: A randomised phase II study of nab -paclitaxel in combination with carboplatin as first line treatment of gastrointestinal neuroendocrine carcinomas (GI-NECs).
Document Type
Academic Journal
Source
Journal of Clinical Oncology (J CLIN ONCOL), 2024 Supplement 3; 42: 589-589. (15p)
Subject
Language
English
ISSN
0732-183X